CO4410201A1 - PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC DISORDERS - Google Patents

PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC DISORDERS

Info

Publication number
CO4410201A1
CO4410201A1 CO95031726A CO95031726A CO4410201A1 CO 4410201 A1 CO4410201 A1 CO 4410201A1 CO 95031726 A CO95031726 A CO 95031726A CO 95031726 A CO95031726 A CO 95031726A CO 4410201 A1 CO4410201 A1 CO 4410201A1
Authority
CO
Colombia
Prior art keywords
treatment
compositions
gastric disorders
pharmaceutical methods
magaldrate
Prior art date
Application number
CO95031726A
Other languages
Spanish (es)
Inventor
Michael Alan Brandley
Dolores Dimaria
Louise Jeanette Brandley
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CO4410201A1 publication Critical patent/CO4410201A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REIVINDICACION NUMERO 1. UNA FORMA DE DOSIFICACION UNITARIA ESTABLE DURAN- TE EL ALMACENAMIENTO DE UNA COMPOSICION FARMACEU- TICA PARA EL TRATAMIENTO DE LOS TRANSTORNOS GAS- TRICOS ASOCIADOS CON LA HIPERACIDEZ DE HUMANOS, LA CUAL COMPRENDE UNA CANTIDAD EFICAZ DE (1) NIZATI- DINA Y (2) UN ANTIACIDO SELECCIONADO DE UN GRUPO CONFORMADO POR CARBONATO DE CALCIO Y MAGALDRATO. REIVINDICACION NUMERO 14. UN METODO DE TRATAMIENTO DE LOS TRANSTORNOS GAS- TROINTESTINALES EN HUMANOS CONSISTENTE EN LA AD- MINISTRACION DE UNA FORMA DE DOSIFICACION UNITA- RIA ESTABLE DURANTE EL ALMACENAMIENTO QUE COMPREN- DE (1) NIZATIDINA Y (2) UN ANTIACIDO SELECCIONADO DE UN GRUPO CONFORMADO POR CARBONATO DE CALCIO Y MAGALDRATO.CLAIM NUMBER 1. A STABLE UNIT DOSAGE FORM DURING THE STORAGE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRIC DISORDERS ASSOCIATED WITH THE HYPERACITY OF HUMANS, WHICH INCLUDES AN EFFICIENT AMOUNT OF (1) AND (2) AN ANTICID SELECTED FROM A GROUP OF CALCIUM CARBONATE AND MAGALDRATE. CLAIMS ISSUE 14. A METHOD OF TREATMENT OF GAS-TROINTESTINAL DISORDERS IN HUMANS CONSISTING OF THE ADMINISTRATION OF A STABLE UNIT DOSAGE FORM DURING THE STORAGE OF (1) NIZATIDINE AND (2) ANTITIED NURSING A GROUP OF CALCIUM CARBONATE AND MAGALDRATE.

CO95031726A 1994-07-20 1995-07-18 PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC DISORDERS CO4410201A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27763294A 1994-07-20 1994-07-20

Publications (1)

Publication Number Publication Date
CO4410201A1 true CO4410201A1 (en) 1997-01-09

Family

ID=23061722

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95031726A CO4410201A1 (en) 1994-07-20 1995-07-18 PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC DISORDERS

Country Status (4)

Country Link
AU (1) AU3132495A (en)
CO (1) CO4410201A1 (en)
PE (1) PE33896A1 (en)
WO (1) WO1996002262A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11433024B2 (en) 2018-04-27 2022-09-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
EP0578732B1 (en) * 1991-04-04 1996-06-19 The Procter & Gamble Company Chewable antacid compositions
ES2077417T3 (en) * 1991-04-04 1995-11-16 Procter & Gamble INGERIBLE PHARMACEUTICAL COMPOSITIONS TO TREAT UPPER GASTROINTESTINAL TRACT DISCOMFORTS.
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
WO1996002262A3 (en) 1997-02-13
AU3132495A (en) 1996-02-16
PE33896A1 (en) 1996-09-02
WO1996002262A2 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
ES515381A0 (en) "DEVICE FOR ENTERTAINMENT FOOD ADMINISTRATION".
IE862554L (en) Pharmaceutical compositions
ES537022A0 (en) A PROCEDURE FOR THE PREPARATION OF A DRUG FORMULATION FOR INTRAVENOUS INJECTION.
NO20053105D0 (en) Oral, extended-release analgesic dosage form for administration ± once per day. day.
DK0600079T3 (en) Oral 1alpha-hydroxypravitamin D
ES511433A0 (en) "PROCEDURE FOR THE PREPARATION OF USEFUL PRODUCTS, PARTICULARLY IN MEDICINES USABLE FOR THE TREATMENT OF MELANOMAS".
DE3381680D1 (en) 1,4-DIHYDROPYRIDINE CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
GR3002487T3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
IT8322832A0 (en) DEVICE FOR THE CONTROLLED ADMINISTRATION OF DRUGS.
PT693285E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A BIPHOSPHONATE AND AN ANTI-RESORCA AGENT TO INHIBIT THE LOSS OSSEA
DK0432117T3 (en) Pharmaceutical preparation for the treatment of inflammation
ES2050363T3 (en) SYSTEM FOR INTRAORAL MEDICINAL RELEASE.
DE3382112D1 (en) PHARMACEUTICAL COMPOSITION.
KR950702120A (en) USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS
WO1992018111A3 (en) Pharmaceutical composition for the treatment of gastritis
ES509179A0 (en) "A METHOD OF MANUFACTURE OF A PHARMACEUTICAL COMPOSITION OF DELAYED DELIVERY IN THE FORM OF PILLS CONTAINING AS A THERAPEUTIC AGENT IBUPROFEN OR FLURBIPROFEN".
CO4410201A1 (en) PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC DISORDERS
AR007650A1 (en) PHARMACEUTICAL COMPOSITION FOR THE PHARMACEUTICAL DOSAGE FORM OF SOFT GELATINE AND FORM OF A DOSAGE THAT INCLUDES IT
EP0268135A3 (en) Coccidiocidal agents
NO874241D0 (en) THERAPEUTIC ACTIVE SALTS.
ITRM920535A1 (en) PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION THROUGH THE MUCOSES.
ES2051706T3 (en) COCCIDIOCID AGENT.
AR018321A1 (en) A DOSAGE FORM OF PROLONGED LIBERATION THAT INCLUDES OXIBUTININE AND THE USES OF OXIBUTININE AND THE DOSAGE FORM OF PROLONGED LIBERATION.
FR2541998B1 (en) (3RS, 4RS) -BENZYL-4-CYANOMETHYL-3- (1'-HYDROXYETHYL) -2-AZETIDINONE